DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,041,815 | -30.1% | 50,500 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $1,490,255 | +28.1% | 50,500 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $1,163,520 | -84.2% | 50,500 | -80.9% | 0.00% | -88.0% |
| Q4 2022 | $7,348,959 | -12.9% | 264,256 | -3.9% | 0.02% | -7.4% |
| Q3 2022 | $8,436,000 | +4.0% | 274,862 | -0.3% | 0.03% | +3.8% |
| Q2 2022 | $8,114,000 | -61.5% | 275,705 | -57.9% | 0.03% | -50.0% |
| Q1 2022 | $21,083,000 | -52.6% | 655,348 | -34.2% | 0.05% | -44.7% |
| Q4 2021 | $44,435,000 | -21.9% | 996,304 | -11.7% | 0.09% | -27.1% |
| Q3 2021 | $56,904,000 | -42.2% | 1,127,919 | -10.1% | 0.13% | -42.7% |
| Q2 2021 | $98,460,000 | +42.5% | 1,255,224 | +3.8% | 0.22% | +32.4% |
| Q1 2021 | $69,081,000 | -22.4% | 1,209,824 | +13.8% | 0.17% | -22.7% |
| Q4 2020 | $89,071,000 | +159.4% | 1,063,406 | +11.0% | 0.22% | +109.5% |
| Q3 2020 | $34,333,000 | +49.0% | 958,206 | +0.6% | 0.10% | +26.5% |
| Q2 2020 | $23,043,000 | +38.1% | 952,957 | 0.0% | 0.08% | +1.2% |
| Q1 2020 | $16,686,000 | +0.5% | 952,957 | 0.0% | 0.08% | +30.2% |
| Q4 2019 | $16,601,000 | +10.0% | 952,957 | -3.2% | 0.06% | +1.6% |
| Q3 2019 | $15,085,000 | -26.2% | 984,662 | 0.0% | 0.06% | -24.4% |
| Q2 2019 | $20,442,000 | -10.6% | 984,662 | 0.0% | 0.08% | -15.5% |
| Q1 2019 | $22,864,000 | +12.5% | 984,662 | +0.1% | 0.10% | -5.8% |
| Q4 2018 | $20,327,000 | -2.1% | 983,902 | +3.0% | 0.10% | +19.8% |
| Q3 2018 | $20,770,000 | +44.1% | 955,402 | +1.1% | 0.09% | +36.5% |
| Q2 2018 | $14,418,000 | -19.8% | 945,462 | +3.5% | 0.06% | -24.1% |
| Q1 2018 | $17,987,000 | +134.7% | 913,525 | +86.4% | 0.08% | +137.1% |
| Q4 2017 | $7,664,000 | – | 490,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |